Margot Mongold
Corporate Officer/Principal bei Society for Human Resources Management
Aktive Positionen von Margot Mongold
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Society for Human Resources Management | Corporate Officer/Principal | - | - |
Karriereverlauf von Margot Mongold
Ehemalige bekannte Positionen von Margot Mongold
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Personalreferent | 01.01.2000 | 01.01.2004 |
| GENVEC INC | Personalreferent | - | - |
| GLYCOMIMETICS, INC. | Personalreferent | 01.01.2018 | - |
Ausbildung von Margot Mongold
| American University | Undergraduate Degree |
| George Washington University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Human Resources Officer | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
| Society for Human Resources Management |
- Börse
- Insiders
- Margot Mongold
- Erfahrung
